Since no significant difference was identified in serum levels of CXCL5 and CXCL10 between early and advanced CTCL, these chemokines might not directly affect CTCL progression. The gene discussed is CXCL5; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.